Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (3414)	12/11/1997 2:41:00 PM
From: j bayer	Respond to of 23519

Whether the drop from 40 to 20 was a result of Viagra's fast track approval or someone's prior knowledge about the apparently severe production setback is anyone's guess. Maybe a combination of both is my guess. If viagra had any affect at all on the stock, can you imagine what it will do to the stock when it gets approved!!! A scarry thought!! It should be right around the time when vvus gets (maybe) the new plant running. We're doomed no matter how you look at it. That ridicules Lancet report makes a this stock a "laughing" stock. Even if the Lancet publication may not be highly respected, just the thought of investing in a drug that gets reviews on its efficacy by tying weights to a man's penis is absurd. It certainly takes credibility away from the publication and VVUS. Last I knew, having intercourse had little to do with the force of gravity on the mans penis. I had to get out and will be licking my wounds for a long time to come. Better luck to you all.